NICE Recommends New Sight Loss Treatment

A new injectable eye medicine has been recommended as a treatment option by the National Institute for Health and Care Excellence (NICE) for two forms of sight loss. The Pharma Times reports that Faricimab has been developed by Roche to treat wet age-related macular...

Promising Results For New Asthma Treatment

A new asthma therapy which is being developed by AstraZeneca in collaboration with Avillion has shown positive results from a phase 3 trial. The Pharma Times reports that the treatment, known as PT027, is a fixed-dose combination of albuterol and budesonide. The novel...